Skip to main content
logo
BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.410
-0.040 (-1.16%)
At close: Aug 12, 2026, 4:00 PM EDT
3.500
+0.090 (2.64%)
After-hours: Aug 12, 2026, 7:49 PM EDT

BriaCell Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Aug - Jul.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Market Cap
3014141079978
Market Cap Growth
517.17%3.03%-87.17%7.72%27.95%1392.31%
Enterprise Value
6.69-4.2812.5585.6758.2120.3
Last Close Price
3.417.50112.501003.50975.00762.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
PB Ratio
1.270.79-5.76-28.319.612.80
P/TBV Ratio
0.460.18--9.970.84

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
EV/EBITDA Ratio
-0.16----
EV/EBIT Ratio
-0.16----
EV/FCF Ratio
-0.15----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Net Debt / Equity Ratio
-0.95-1.000.365.63-3.97-2.07
Net Debt / EBITDA Ratio
0.770.660.030.912.698.23
Net Debt / FCF Ratio
0.740.630.040.903.297.39
Quick Ratio
7.075.010.4914.9643.64102.88
Current Ratio
7.075.010.4914.9645.00103.81
Return on Equity (ROE)
-190.19%-362.56%152.63%-619.75%-141.25%-114.78%
Return on Assets (ROA)
-162.91%-197.69%-201.78%-66.74%-30.39%-23.82%
Return on Invested Capital (ROIC)
-2038.57%-1380.42%-1053.18%-989.19%-3640.60%-1844.83%
Return on Capital Employed (ROCE)
-194.77%-338.31%-280.40%-69.47%-30.85%-25.82%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Buyback Yield / Dilution
-1260.31%-285.70%-5.35%-0.81%-242.82%-
Total Shareholder Return
-1260.31%-285.70%-5.35%-0.81%-242.82%-
SEC Filings: 10-K · 10-Q